IP Library Granted Patent US 10,653,763
Granted Patent B2
US 10,653,763 · App. 15/488,866 · Granted May 19, 2020

Subunit immersion vaccines for fish

Inventors: Elizabeth Mary Crump (Florham Park, NJ); Jan Burian (Florham Park, NJ); Joseph Michale Bricker (Florham Park, NJ); William Wayne Kay (Florham Park, NJ); Norman William Johnson (Florham Park, NJ)
Assignee: BENCHMARK ANIMAL HEALTH LIMITED
A61K39/02A61K39/0208A61K39/0216A61K39/12A61K2039/54A61K2039/552A61K2039/70C12N2720/10034
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,763
App. No.
15/488,866
Granted
May 19, 2020
Kind
B2
Abstract

The present disclosure provides an immersion vaccine for fish comprising at least one isolated antigen, specifically a recombinant antigen, such as is F. psychrophilum and/or infectious pancreatic necrosis virus (IPNV).

Claims (7)

1. A vaccine for fish comprising an antigenic fusion protein, wherein the antigenic fusion protein has a leader sequence consisting of the amino acid sequence of residues 1-90 of SEQ ID NO:7, and an antigenic fragment comprising an amino acid sequence of a histone like protein (HLP) from Tenacibaculum maritimum ( T. maritimum ), Flavobacterium columnare ( F. columnare ) or Flavobacterium psychrophilum ( F. psychrophilum );

wherein the amino acid sequence of the HLP from T maritimum has the amino acid sequence of SEQ ID NO:2, wherein the amino acid sequence of the HLP from F. columnare has the amino acid sequence of SEQ ID NO:4, and wherein the amino acid sequence of the HLP from F. psychrophilum has the amino acid sequence of SEQ ID NO:6.

2. The vaccine of claim 1 , wherein the antigenic fusion protein comprises an immunostimulatory fragment consisting of the amino acid sequence of residues 97-111 of SEQ ID NO:7.

3. The vaccine of claim 1 , wherein the vaccine further comprises at least a second different isolated antigen.

4. The vaccine of claim 3 , wherein the second isolated antigen is an infectious pancreatic necrosis virus (IPNV) antigen.

5. The vaccine of claim 1 , further comprising at least one additional agent selected from the group consisting of Aeromonas hydrophilia, Aeromonas salmonicida, Pseudomonas fluorescens, Vibrio anguillarum, Vibrio salmonicida, Renibacterium salmoninarum , infectious haemopoietic necrosis virus (IHNV), infectious salmon anemia virus (ISAV), pancreas disease virus (PDV), salmon alphavirus (SAV), salmon poxvirus, and viral haemorrhagic septicemia virus (VHSV).

6. A method of immunizing a fish comprising administering to said fish an immunologically effective amount of the vaccine of any one of claims 1 , 2 , and 3 - 5 , wherein the method immunizes the fish against F. columnare, F. psychrophilum , or T. maritimum.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2020
From: FVG LIMITED
To: BENCHMARK ANIMAL HEALTH LIMITED
Reel/Frame 051793/0374 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2017
From: CRUMP, ELIZABETH MARY; BURIAN, JAN; BRICKER, JOSEPH MICHAEL; KAY, WILLIAM WAYNE; JOHNSON, NORMAN WILLIAM
To: AH USA 42 LLC
Reel/Frame 042030/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2017
From: ZOETIS LLC
To: ZOETIS CANADA INC.
Reel/Frame 042030/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2017
From: ZOETIS CANADA INC.
To: FVG LIMITED
Reel/Frame 042030/0255 →
CHANGE OF NAME Recorded Apr 17, 2017
From: AH USA 42 LLC
To: ZOETIS LLC
Reel/Frame 042269/0533 →
Continuity (3)
Division 14431349
Provisional Application 61705704 · Sep 26, 2012
Related Publication 20170348406A1 · Dec 7, 2017